Targeted radionuclide therapy enhances prostate cancer response to immunotherapies
Targeted radionuclide therapy has been found to create a favourable tumour microenvironment in prostate cancer…
Browsing: Society of Nuclear Medicine and Molecular Imaging’s 2020 Annual Meeting
New theranostic agents show efficacy in prostate cancer treatment in preclinical studies
Researchers have developed a new pair of agents that show exceptional effectiveness for precision diagnosis…